Resistant hypertension
MONDO:0100078A severe medical condition which is estimated to appear in 9-18% of hypertensive patients, in which treatment with 3 or more antihypertensive drugs including diuretics are ineffective.
Also known as: drug resistant hypertension
41 clinical trials for this condition and its sub-types.
Follow this condition — get notified about new trialsBroader categories
-
New device zaps kidney nerves to tame stubborn high blood pressure
Disease control Recruiting nowThis early study tests a new device called HyperQure that uses a keyhole surgery to disable certain nerves around the kidneys. The goal is to help people with resistant hypertension—high blood pressure that stays high despite taking three or more medications. The study will enrol…
Phase: NA • Sponsor: DeepQure Inc. • Aim: Disease control
Last updated Aug 12, 2026 00:00 UTC
-
Couples who sleep together, get healthy together? new study tests sleep program for partners
Disease control Recruiting nowThis pilot study tests whether a sleep health program designed for couples can improve sleep and blood pressure. Fifty couples will take part in an 8-week program that includes sleep education, coaching, and a Fitbit to track sleep. The goal is to see if working together as a tea…
Phase: NA • Sponsor: Columbia University • Aim: Disease control
Last updated Jun 27, 2026 13:06 UTC
-
Beetroot breakthrough? new study tests natural BP fix for tough hypertension
Disease control Recruiting nowThis study tests whether beetroot powder, which is rich in nitrates, can help lower blood pressure in people with resistant hypertension (high blood pressure that doesn't respond well to standard medications). Researchers will monitor blood pressure changes in 50 participants ove…
Phase: EARLY_PHASE1 • Sponsor: National Institute of Cardiology, Laranjeiras, Brazil • Aim: Disease control
Last updated Jun 27, 2026 12:06 UTC
-
New injection aims to tame stubborn high blood pressure in kidney patients
Disease control Recruiting nowThis early study tests a new medicine called SC101, given as a single injection around the kidneys, for people with resistant high blood pressure and moderate to severe chronic kidney disease. The main goal is to check safety, with only 3 participants. Researchers will also monit…
Phase: PHASE1 • Sponsor: The First Affiliated Hospital with Nanjing Medical University • Aim: Disease control
Last updated Jun 27, 2026 12:01 UTC
-
Old antibiotic, new trick: could minocycline tame resistant hypertension?
Disease control Recruiting nowThis study tests whether the antibiotic minocycline can lower blood pressure in people whose hypertension does not respond to standard treatments. Researchers will give 120 adults either minocycline or a placebo daily for three months to see if the drug works by changing gut bact…
Phase: PHASE4 • Sponsor: University of Florida • Aim: Disease control
Last updated Jun 27, 2026 09:11 UTC
-
New hope for stubborn high blood pressure: drug targets blood vessels
Disease control Recruiting nowThis study is for people with resistant hypertension, meaning their blood pressure stays high even with three or more medications. Researchers want to see if a drug that blocks endothelin-1, a substance that tightens blood vessels, can improve blood vessel function and lower bloo…
Phase: PHASE2 • Sponsor: University Hospital, Rouen • Aim: Disease control
Last updated Jun 27, 2026 09:05 UTC
-
Shocking news: TENS therapy plus exercise may tame stubborn high blood pressure
Disease control Recruiting nowThis study tests whether combining transcutaneous electrical nerve stimulation (TENS) with isometric exercise can improve blood pressure in people with resistant hypertension. Resistant hypertension means blood pressure stays high despite taking three or more medications. The tri…
Phase: NA • Sponsor: Mohamed Mohamed Ali Morgan • Aim: Disease control
Last updated Jun 27, 2026 09:01 UTC
-
One pill to rule them all? new combo tackles resistant hypertension
Disease control Recruiting nowThis study tests whether a single daily pill containing three blood pressure medications can better control resistant hypertension compared to taking multiple separate drugs. Researchers will enroll 142 adults with high blood pressure that is not well controlled despite using 3 t…
Phase: NA • Sponsor: Instituto Dante Pazzanese de Cardiologia • Aim: Disease control
Last updated Jun 27, 2026 08:00 UTC
-
New device could help patients with Hard-to-Control blood pressure
Disease control Recruiting nowThis study follows 500 people in China with resistant hypertension who have already received the Symplicity Spyral renal denervation system. The device uses radiofrequency energy to calm overactive kidney nerves that can raise blood pressure. Researchers will track blood pressure…
Sponsor: Medtronic Vascular • Aim: Disease control
Last updated Jun 27, 2026 07:57 UTC
-
New shot could tame stubborn high blood pressure
Disease control Recruiting nowThis study tests a daily injection called MANP for people whose high blood pressure remains high despite taking three or more different medications. About 120 adults aged 18 to 80 will receive either MANP or a placebo for 42 days. The main goal is to see if MANP safely lowers day…
Phase: PHASE2 • Sponsor: E-Star BioTech, LLC • Aim: Disease control
Last updated Jun 27, 2026 07:53 UTC
-
New hope for dialysis patients with stubborn high blood pressure?
Disease control Recruiting nowThis study tests a procedure called renal denervation, which uses ultrasound to calm overactive kidney nerves, in 12 dialysis patients with hard-to-treat high blood pressure. The goal is to see if it safely lowers blood pressure over 3 to 6 months. It is a small, early-stage tria…
Phase: NA • Sponsor: University of Erlangen-Nürnberg Medical School • Aim: Disease control
Last updated Jun 27, 2026 07:51 UTC
-
Egg white extract could help tame blood sugar and pressure
Symptom relief Recruiting nowThis early study tests whether a peptide called IRW, found in egg white hydrolysate, can help manage high blood sugar and blood pressure. About 28 participants at risk for or with type 2 diabetes will consume a smoothie with the peptide on four separate days, while a healthy cont…
Phase: PHASE1 • Sponsor: University of Alberta • Aim: Symptom relief
Last updated Jun 27, 2026 11:01 UTC